Details for New Drug Application (NDA): 217060
The generic ingredient in BRAVNETSA is lutetium lu-177 dotatate. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the lutetium lu-177 dotatate profile page.
Summary for 217060
| Tradename: | BRAVNETSA |
| Applicant: | Lantheus Medical |
| Ingredient: | lutetium lu-177 dotatate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10mCi/ML | ||||
| Approval Date: | Sep 21, 2026 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
